These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies. Archer GL; Johnston JL; Vazquez GJ; Haywood HB Rev Infect Dis; 1983; 5 Suppl 3():S538-42. PubMed ID: 6556710 [TBL] [Abstract][Full Text] [Related]
50. Clinical characteristics of infections in humans due to Staphylococcus epidermidis. Rupp ME Methods Mol Biol; 2014; 1106():1-16. PubMed ID: 24222451 [TBL] [Abstract][Full Text] [Related]
51. Effect of trans(NO, OH)-[RuFT(Cl)(OH)NO](PF Bocé M; Tassé M; Mallet-Ladeira S; Pillet F; Da Silva C; Vicendo P; Lacroix PG; Malfant I; Rols MP Sci Rep; 2019 Mar; 9(1):4867. PubMed ID: 30890745 [TBL] [Abstract][Full Text] [Related]
52. Pathogenic infection caused by coagulase negative multiple drug resistant Staphylococcus. Aggarwal P J Indian Med Assoc; 1991 Jan; 89(1):15-6. PubMed ID: 2051034 [TBL] [Abstract][Full Text] [Related]
53. Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period. Lyytikäinen O; Vaara M; Järviluoma E; Rosenqvist K; Tiittanen L; Valtonen V Eur J Clin Microbiol Infect Dis; 1996 Feb; 15(2):133-8. PubMed ID: 8801085 [TBL] [Abstract][Full Text] [Related]
56. Community-acquired methicillin-resistant Staphylococcus epidermidis pyelonephritis in a child: a case report. Kanai H; Sato H; Takei Y J Med Case Rep; 2014 Dec; 8():415. PubMed ID: 25488491 [TBL] [Abstract][Full Text] [Related]
57. Immunoprophylaxis and immunotherapy of Staphylococcus epidermidis infections: challenges and prospects. Van Mellaert L; Shahrooei M; Hofmans D; Eldere JV Expert Rev Vaccines; 2012 Mar; 11(3):319-34. PubMed ID: 22380824 [TBL] [Abstract][Full Text] [Related]